AMANDA ALBERDING: Open Payments
NPI 1346597630 · SOUTH BEND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,310 in 83 payments from 14 companies in 2025. Trend: 2023 $759 · 2024 $742 · 2025 $1,310
Food & beverage: $1,267Education: $43
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $368 |
| Galderma Laboratories, L.P. | 15 | $222 |
| Novartis Pharmaceuticals Corporation | 11 | $175 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $123 |
| Organon LLC | 10 | $123 |
| GENZYME CORPORATION | 3 | $80 |
| Janssen Biotech, Inc. | 2 | $70 |
| Regeneron Healthcare Solutions, Inc. | 2 | $38 |
| Lilly USA, LLC | 2 | $34 |
| UCB, Inc. | 1 | $17 |
Products named: SKYRIZI, NEMLUVIO, DUPIXENT, Leqselvi, COSENTYX, RINVOQ, TREMFYA, HADLIMA.
Industry payments across IN — which companies pay providers there.
